Profound Medical Corp
TSX:PRN
Profound Medical Corp
Interest Income Expense
Profound Medical Corp
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Interest Income Expense
$5.2m
|
CAGR 3-Years
231%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Titan Medical Inc
TSX:TMD
|
Interest Income Expense
$327k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Interest Income Expense
-CA$3.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Interest Income Expense
CA$32.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Interest Income Expense
-CA$942.2k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Interest Income Expense
CA$63k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
See Also
What is Profound Medical Corp's Interest Income Expense?
Interest Income Expense
5.2m
USD
Based on the financial report for Dec 31, 2024, Profound Medical Corp's Interest Income Expense amounts to 5.2m USD.
What is Profound Medical Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
231%
Over the last year, the Interest Income Expense growth was 7 968%. The average annual Interest Income Expense growth rates for Profound Medical Corp have been 231% over the past three years .
You don't have any saved screeners yet